Salivary Gland Infection Market Anticipated To Witness Robust Growth, Surpassing 6.09 Billion By 2029

We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

What Is the Current Salivary Gland Infection Market Size and Its Estimated Growth Rate?
The market for salivary gland infections has seen robust growth in the past few years. It is projected to expand from $4.12 billion in 2024 to $4.46 billion in 2025, with a compound annual growth rate (CAGR) of 8.4%. Several factors contributed to this growth in the historic period, including an increase in oral health problems, heightened awareness of salivary disorders, a growing prevalence of bacterial and viral infections, expansion of healthcare infrastructure, a rise in the elderly population, and an increase in the uptake of minimally invasive treatments.

The market size of salivary gland infections is anticipated to witness substantial growth over the following years, expectedly reaching a value of $6.09 billion in 2029, with a compound annual growth rate of 8.1%. Factors contributing to this projected growth during the forecast period include growing awareness of oral healthcare, increasing uptake of minimally invasive methods, a rise in chronic disease prevalence, enhancements in health infrastructure, and broadening of patient access to specialist care. Key trends projected for the forecast period encompass increased use of minimally invasive techniques, advancements in sialendoscopy, advanced imagery technology, development of biocompatible stents, increased use of robotic-assisted surgeries, targeted antimicrobial treatments, and diagnostics tools powered by artificial intelligence.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21281

How Are Emerging Segments Shaping the Salivary Gland Infection Market Landscape?
The salivary gland infection market covered in this report is segmented -

1) By Diagnosis: Plain Radiography, Sialography, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Radionuclide Scintigraphy, High-resolution Ultrasonography, Other Diagnoses
2) By Treatment: Medications, Surgery, Aspiration, Home Care, Other Treatments
3) By End User: Hospitals And Clinics, Medical Research Centers, Academic Institutes, Other End User

Subsegments:
1) By Plain Radiography: X-ray Of Salivary Glands, Sialography With X-ray
2) By Sialography: Conventional Sialography, Digital Subtraction Sialography (DSS)
3) By Computed Tomography (CT): Non-contrast CT, Contrast-enhanced CT
4) By Magnetic Resonance Imaging (MRI): MRI without contrast, MRI With contrast (Dynamic MRI)
5) By Radionuclide Scintigraphy: Planar Scintigraphy, SPECT (Single Photon Emission Computed Tomography)
6) By High-resolution Ultrasonography: Standard Ultrasonography, Doppler Ultrasonography
7) By Other Diagnoses: Fine Needle Aspiration (FNA) Biopsy, Endoscopy, Salivary Flow Test

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21281&type=smp

Which Growth Factors Are Influencing Salivary Gland Infection Market Expansion?
Increased instances of oral health complications are anticipated to propel the growth of the market for salivary gland infections. These oral health complications comprise conditions such as tooth decay, gum diseases, and other oral issues. The spike in such problems can be attributed to poor oral sanitation, unhealthy dietary habits, and lack of access to proper dental care. These issues escalate the possibility of salivary gland infections by fostering bacterial growth and creating obstructions in the salivary conduits. For example, the National Health Service (NHS), a UK-based governmental organization, reported in May 2024 that 32.5 million dental treatments were performed in 2022-23, marking a 23.2% augmentation as opposed to the preceding year. Hence, the escalating issues related to oral health is fueling the growth of the salivary gland infections market.

Who Are the Dominant Players Across Different Salivary Gland Infection Market Segments?
Major companies operating in the salivary gland infection market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., AstraZeneca plc, Novartis AG, GSK plc, Eli Lilly and Company, Gilead Sciences, Inc., Amgen Inc., FUJIFILM Holdings Corporation, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Astellas Pharma Inc., Sandoz International GmbH, Vertex Pharmaceuticals Incorporated, Incyte Corporation., Hikma Pharmaceuticals PLC, Lupin Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Vanda Pharmaceuticals Inc., Mylan N.V., Zydus Cadila Healthcare Ltd.

What Are the Latest Developing Trends in the Salivary Gland Infection Market?
In the salivary gland infections market, leading companies are giving priority to technological advancements, especially in the field of minimally invasive procedures. Their objective is to enhance treatment results, speed up patient recuperation, and boost overall medical efficiency. These minimally invasive procedures include smaller cuts and specialized devices leading to reduced tissue damage and faster recovery. For illustration, Amrita Hospital, a healthcare institution from India, in March 2024, inaugurated the Amrita Centre for minimal invasive salivary gland surgery. The aim is to provide a revolutionary treatment for salivary disorders through sialendoscopy, reducing the necessity for surgical intervention, and maintaining gland function. This inaugural was marked by a two-day workshop displaying expert demonstrations.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/salivary-gland-infection-global-market-report

Which Geographic Regions Are Expected to Dominate the Salivary Gland Infection Market in the Coming Years?
North America was the largest region in the salivary gland infection market in 2024. The regions covered in the salivary gland infection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Salivary Gland Infection Market?
2. What is the CAGR expected in the Salivary Gland Infection Market?
3. What Are the Key Innovations Transforming the Salivary Gland Infection Industry?
4. Which Region Is Leading the Salivary Gland Infection Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.